Physician profile
Abdollah Moshrefi
NPI 1871707158
$2,964.63
in general payments reported to CMS, 2019-2025
11 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $176 · 2021: $140 · 2022: $108 · 2023: $1,634 · 2024: $444 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589 · Entertainment: $500 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.88 |
| Entertainment | $500.00 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $1,504.56 | 2019-2024 | Orthophos E |
| Biohorizons Implant Systems INC. | $581.44 | 2019-2025 | Biohorizons, Biohorizons Dental Implants, Biohorizons Dental Prosthetics |
| Keystone Dental INC. | $363.31 | 2024 | |
| Hu-Friedy Mfg. Co., LLC | $212.14 | 2020-2021 | |
| Biolase, INC. | $77.79 | 2019 | |
| Henry Schein, INC. | $68.39 | 2023 | |
| Align Technology, INC. | $62.77 | 2024-2025 | Invisalign |
| Nobel Biocare USA | $47.21 | 2019-2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $22.14 | 2025 | Arestin |
| Straumann USA LLC | $12.50 | 2021 | |
| Philips North America LLC | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdollah Moshrefi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.